Preliminary Results: Comparison of Convolutional Neural Network Architectures as an Auxiliary Clinical Tool Applied to Screening Mammography in Mexican Women-Reference-Cited by-同舟云学术

Preliminary Results: Comparison of Convolutional Neural Network Architectures as an Auxiliary Clinical Tool Applied to Screening Mammography in Mexican Women

Published:2024-05-09 Issue:3 Volume:44 Page:390-400
ISSN:1609-0985
Container-title:Journal of Medical and Biological Engineering
language:en
Short-container-title:J. Med. Biol. Eng.

Author:

Acosta-Jiménez Samara,González-Chávez Susana Aideé,Camarillo-Cisneros Javier,Pacheco-Tena César,Barcenas-López Mirelle,González-Lozada Laura Esther,Hernández-Orozco Claudia,Burboa-Delgado Jesús Humberto,Ochoa-Albíztegui Rosa Elena^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40846-024-00868-6.pdf

Reference39 articles.

1. Sung, H., & Global Cancer Statistics. (2020). : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA: A Cancer Journal for Clinicians, vol. 71, no. 3, pp. 209–249, 2021, https://doi.org/10.3322/caac.21660.

2. Lei, S., et al. (2021). Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Communications, 41(11), 1183–1194. https://doi.org/10.1002/cac2.12207.

3. INEGI Estadísticas a propósito del día mundial de la lucha contra el cáncer de mama. Oct. 18, 2021. Accessed: Sep. 25, 2023. [Online]. Available: https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2021/EAP_LUCHACANCER2021.pdf.

4. Secretaria de, & Salud Programa de Acción Específico Prevención y Control del Cáncer de la Mujer 2013–2018, gob.mx. Accessed: Sep. 30, 2023. [Online]. Available: http://www.gob.mx/salud/documentos/programa-de-accion-especifico-prevencion-y-control-del-cancer-de-la-mujer-2013-2018.

5. Gutiérrez, G. L. V., García, A. M., Benavente, E. P. L., Mejía, F. H., Gómez, R. T., & Villalón, F. R. (Oct. 2023). Non–timely referral of women aged 40 to 69 to preventive medicine for breast cancer detection and its association with the BI-RADS classification. Preventive Medicine Reports, 35, 102369. https://doi.org/10.1016/j.pmedr.2023.102369.